REPORTS

Let’s Pullulate and Expand Your Business

Right Ventricular Assist Systems (Rvas) Market - Global Professional Analysis and Forecast to 2026

Oct 25, 2019  |  191 PAGES  |  REPORT CODE: CMM223704
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Right Ventricular Assist Systems (Rvas) market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.9% during the forecast period.

This report presents the market size and development trends by detailing the Right Ventricular Assist Systems (Rvas) market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Right Ventricular Assist Systems (Rvas) market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Right Ventricular Assist Systems (Rvas) industry and will help you to build a panoramic view of the industrial development.

Right Ventricular Assist Systems (Rvas) Market, By Type:

  • Type 1

  • Type 2

  • Type 3

Right Ventricular Assist Systems (Rvas) Market, By Application:

  • End-User 1

  • End-User 2

  • End-User 3

Some of the leading players are as follows:

  • SynCardia Systems, Inc. (USA)

  • Baxter International, Inc. (USA)

  • Abbott Diabetes Care, Inc. (USA)

  • Vital Therapies, Inc. (USA)

  • Toray Medical Co., Ltd. (Japan)

  • Xenios AG (Germany)

  • Fresenius Medical Care AG & Co. KGaA (Germany)

  • Nikkiso Co., Ltd. (Japan)

  • Thoratec Corp. (USA)

  • Medtronic, Inc. (USA)

  • HeartWare International, Inc. (USA)

  • Nipro Corporation (Japan)

  • Asahi Kasei Medical Co., Ltd. (Japan)

  • Jarvik Heart, Inc. (USA)

  • Terumo Heart, Inc. (USA)

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Right Ventricular Assist Systems (Rvas) Market: Technology Type Analysis

  • 4.1 Right Ventricular Assist Systems (Rvas) Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Right Ventricular Assist Systems (Rvas) Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Type 1

    • 4.3.2 Type 2

    • 4.3.3 Type 3

5 Right Ventricular Assist Systems (Rvas) Market: Product Analysis

  • 5.1 Right Ventricular Assist Systems (Rvas) Product Market Share Analysis, 2018 & 2026

  • 5.2 Right Ventricular Assist Systems (Rvas) Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Right Ventricular Assist Systems (Rvas) Market: Application Analysis

  • 6.1 Right Ventricular Assist Systems (Rvas) Application Market Share Analysis, 2018 & 2026

  • 6.2 Right Ventricular Assist Systems (Rvas) Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 End-User 1

    • 6.3.2 End-User 1

    • 6.3.3 End-User 3

7 Right Ventricular Assist Systems (Rvas) Market: Regional Analysis

  • 7.1 Right Ventricular Assist Systems (Rvas) Regional Market Share Analysis, 2018 & 2026

  • 7.2 Right Ventricular Assist Systems (Rvas) Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 SynCardia Systems, Inc. (USA)

    • 9.1.1 SynCardia Systems, Inc. (USA) Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Baxter International, Inc. (USA)

    • 9.2.1 Baxter International, Inc. (USA) Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Abbott Diabetes Care, Inc. (USA)

    • 9.3.1 Abbott Diabetes Care, Inc. (USA) Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Vital Therapies, Inc. (USA)

    • 9.4.1 Vital Therapies, Inc. (USA) Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Toray Medical Co., Ltd. (Japan)

    • 9.5.1 Toray Medical Co., Ltd. (Japan) Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Xenios AG (Germany)

    • 9.6.1 Xenios AG (Germany) Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Fresenius Medical Care AG & Co. KGaA (Germany)

    • 9.7.1 Fresenius Medical Care AG & Co. KGaA (Germany) Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Nikkiso Co., Ltd. (Japan)

    • 9.8.1 Nikkiso Co., Ltd. (Japan) Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Thoratec Corp. (USA)

    • 9.9.1 Thoratec Corp. (USA) Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Medtronic, Inc. (USA)

    • 9.10.1 Medtronic, Inc. (USA) Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 HeartWare International, Inc. (USA)

    • 9.11.1 HeartWare International, Inc. (USA) Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Nipro Corporation (Japan)

    • 9.12.1 Nipro Corporation (Japan) Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Asahi Kasei Medical Co., Ltd. (Japan)

    • 9.13.1 Asahi Kasei Medical Co., Ltd. (Japan) Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Jarvik Heart, Inc. (USA)

    • 9.14.1 Jarvik Heart, Inc. (USA) Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 Terumo Heart, Inc. (USA)

    • 9.15.1 Terumo Heart, Inc. (USA) Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

 

The List of Tables and Figures (Totals 91 Figures and 150 Tables)

  • Figure Type 1 Right Ventricular Assist Systems (Rvas) market, 2015 - 2026 (USD Million)

  • Figure Type 2 Right Ventricular Assist Systems (Rvas) market, 2015 - 2026 (USD Million)

  • Figure Type 3 Right Ventricular Assist Systems (Rvas) market, 2015 - 2026 (USD Million)

  • Figure End-User 1 market, 2015 - 2026 (USD Million)

  • Figure End-User 2 market, 2015 - 2026 (USD Million)

  • Figure End-User 3 market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Right Ventricular Assist Systems (Rvas) market, by country, 2015 - 2026 (USD Million)

  • Table North America Right Ventricular Assist Systems (Rvas) market, by type, 2015 - 2026 (USD Million)

  • Table North America Right Ventricular Assist Systems (Rvas) market, by product, 2015 - 2026 (USD Million)

  • Table North America Right Ventricular Assist Systems (Rvas) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Right Ventricular Assist Systems (Rvas) market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Right Ventricular Assist Systems (Rvas) market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Right Ventricular Assist Systems (Rvas) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Right Ventricular Assist Systems (Rvas) market, by type, 2015 - 2026 (USD Million)

  • Table Canada Right Ventricular Assist Systems (Rvas) market, by product, 2015 - 2026 (USD Million)

  • Table Canada Right Ventricular Assist Systems (Rvas) market, by application, 2015 - 2026 (USD Million)

  • Table Europe Right Ventricular Assist Systems (Rvas) market, by country, 2015 - 2026 (USD Million)

  • Table Europe Right Ventricular Assist Systems (Rvas) market, by type, 2015 - 2026 (USD Million)

  • Table Europe Right Ventricular Assist Systems (Rvas) market, by product, 2015 - 2026 (USD Million)

  • Table Europe Right Ventricular Assist Systems (Rvas) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Right Ventricular Assist Systems (Rvas) market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Right Ventricular Assist Systems (Rvas) market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Right Ventricular Assist Systems (Rvas) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Right Ventricular Assist Systems (Rvas) market, by type, 2015 - 2026 (USD Million)

  • Table Germany Right Ventricular Assist Systems (Rvas) market, by product, 2015 - 2026 (USD Million)

  • Table Germany Right Ventricular Assist Systems (Rvas) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Right Ventricular Assist Systems (Rvas) market, by type, 2015 - 2026 (USD Million)

  • Table France Right Ventricular Assist Systems (Rvas) market, by product, 2015 - 2026 (USD Million)

  • Table France Right Ventricular Assist Systems (Rvas) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Right Ventricular Assist Systems (Rvas) market, by type, 2015 - 2026 (USD Million)

  • Table Italy Right Ventricular Assist Systems (Rvas) market, by product, 2015 - 2026 (USD Million)

  • Table Italy Right Ventricular Assist Systems (Rvas) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Right Ventricular Assist Systems (Rvas) market, by type, 2015 - 2026 (USD Million)

  • Table Spain Right Ventricular Assist Systems (Rvas) market, by product, 2015 - 2026 (USD Million)

  • Table Spain Right Ventricular Assist Systems (Rvas) market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Right Ventricular Assist Systems (Rvas) market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Right Ventricular Assist Systems (Rvas) market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Right Ventricular Assist Systems (Rvas) market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Right Ventricular Assist Systems (Rvas) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Right Ventricular Assist Systems (Rvas) market, by type, 2015 - 2026 (USD Million)

  • Table China Right Ventricular Assist Systems (Rvas) market, by product, 2015 - 2026 (USD Million)

  • Table China Right Ventricular Assist Systems (Rvas) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Right Ventricular Assist Systems (Rvas) market, by type, 2015 - 2026 (USD Million)

  • Table Japan Right Ventricular Assist Systems (Rvas) market, by product, 2015 - 2026 (USD Million)

  • Table Japan Right Ventricular Assist Systems (Rvas) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Right Ventricular Assist Systems (Rvas) market, by type, 2015 - 2026 (USD Million)

  • Table India Right Ventricular Assist Systems (Rvas) market, by product, 2015 - 2026 (USD Million)

  • Table India Right Ventricular Assist Systems (Rvas) market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Right Ventricular Assist Systems (Rvas) market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Right Ventricular Assist Systems (Rvas) market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Right Ventricular Assist Systems (Rvas) market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Right Ventricular Assist Systems (Rvas) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Right Ventricular Assist Systems (Rvas) market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Right Ventricular Assist Systems (Rvas) market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Right Ventricular Assist Systems (Rvas) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Right Ventricular Assist Systems (Rvas) market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Right Ventricular Assist Systems (Rvas) market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Right Ventricular Assist Systems (Rvas) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Right Ventricular Assist Systems (Rvas) market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Right Ventricular Assist Systems (Rvas) market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Right Ventricular Assist Systems (Rvas) market, by application, 2015 - 2026 (USD Million)

  • Table MEA Right Ventricular Assist Systems (Rvas) market, by country, 2015 - 2026 (USD Million)

  • Table MEA Right Ventricular Assist Systems (Rvas) market, by type, 2015 - 2026 (USD Million)

  • Table MEA Right Ventricular Assist Systems (Rvas) market, by product, 2015 - 2026 (USD Million)

  • Table MEA Right Ventricular Assist Systems (Rvas) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Right Ventricular Assist Systems (Rvas) market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Right Ventricular Assist Systems (Rvas) market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Right Ventricular Assist Systems (Rvas) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Right Ventricular Assist Systems (Rvas) market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Right Ventricular Assist Systems (Rvas) market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Right Ventricular Assist Systems (Rvas) market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table SynCardia Systems, Inc. (USA) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Baxter International, Inc. (USA) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Abbott Diabetes Care, Inc. (USA) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Vital Therapies, Inc. (USA) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Toray Medical Co., Ltd. (Japan) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Xenios AG (Germany) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Fresenius Medical Care AG & Co. KGaA (Germany) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Nikkiso Co., Ltd. (Japan) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Thoratec Corp. (USA) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Medtronic, Inc. (USA) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table HeartWare International, Inc. (USA) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Nipro Corporation (Japan) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Asahi Kasei Medical Co., Ltd. (Japan) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Jarvik Heart, Inc. (USA) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Terumo Heart, Inc. (USA) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top